Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reveals strong support and curiosity, with posts like 'Strong work from our amazing Epilepsy Fellow' and references to investigative details such as 'functional and pharmacological evaluation' indicating an appreciation for the research. The frequent use of hashtags related to ion channels and epilepsy shows interest in the topic's relevance, fostering a sense of impact within the scientific community.
Most discussions recognize the importance and relevance of the research, with some expressing admiration for the work or its significance.
There is high interest in the topic, as evidenced by frequent mentions of specific genes, epilepsy, and ion channels, showing engagement with the scientific content.
The posts include praise for the researchers and references to related terms, indicating a moderate level of engagement and curiosity about the findings and methods.
The discussions suggest the publication is considered meaningful within the neuroscience and epilepsy research community, though some comments remain general.
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy. #ionchannels #scn2a #epilepsy https://t.co/xRU5OBCLX8
Functional and pharmacological evaluation of a novel SCN2A variant linked to early‐onset epilepsy https://t.co/62NWIQLZrc
Strong work from our amazing Epilepsy Fellow and former @NMNeurons Dr. Scott Adney. @NMNeurology Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy https://t.co/2ra0neW5et
Some Tuesday reading: 'Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy' https://t.co/GxeUoeuZXi #scn2a #ionchannels #epilepsy
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy https://t.co/72Hs4VvKjY #bioRxiv
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy https://t.co/MlfS3QlSgN #biorxiv_neursci
This AI podcast discusses recent research on SCN2A-related disorders, focusing on a novel variant linked to early-onset epilepsy. It covers functional and pharmacological evaluations from recent publications.
The KI Podcast discusses recent research on a novel SCN2A variant linked to early-onset epilepsy, focusing on functional and pharmacological evaluations based on scientific papers.
Strong work from our amazing Epilepsy Fellow and former @NMNeurons Dr. Scott Adney. @NMNeurology Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy https://t.co/2ra0neW5et
RT @NatRevNeurol: Functional and pharmacological evaluation of a novel SCN2A variant linked to early‐onset epilepsy https://t.co/62NWIQLZrc
RT @NatRevNeurol: Functional and pharmacological evaluation of a novel SCN2A variant linked to early‐onset epilepsy https://t.co/62NWIQLZrc
Functional and pharmacological evaluation of a novel SCN2A variant linked to early‐onset epilepsy https://t.co/62NWIQLZrc
Some Tuesday reading: 'Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy' https://t.co/GxeUoeuZXi #scn2a #ionchannels #epilepsy
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy. #ionchannels #scn2a #epilepsy https://t.co/xRU5OBCLX8
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy https://t.co/72Hs4VvKjY #bioRxiv
Functional and Pharmacological Evaluation of a Novel SCN2A Variant Linked to Early-onset Epilepsy https://t.co/MlfS3QlSgN #biorxiv_neursci
DN
NN
SV
B
BN
EP
RP